{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:30:55Z","timestamp":1773761455968,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T00:00:00Z","timestamp":1357257600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s10549-012-2392-y","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T08:34:43Z","timestamp":1357202083000},"page":"709-719","source":"Crossref","is-referenced-by-count":29,"title":["Elevated expression of podocalyxin is associated with lymphatic invasion, basal-like phenotype, and clinical outcome in axillary lymph node-negative breast cancer"],"prefix":"10.1007","volume":"137","author":[{"given":"Catherine L.","family":"Forse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yildiz E.","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dushanthi","family":"Pinnaduwage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances P.","family":"O\u2019Malley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Marie","family":"Mulligan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley B.","family":"Bull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene L.","family":"Andrulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,4]]},"reference":[{"key":"2392_CR1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1200\/JCO.2004.09.128","volume":"22","author":"SB Bull","year":"2004","unstructured":"Bull SB, Ozcelik H, Pinnaduwage D, Blackstein ME, Sutherland DA, Pritchard KI, Tzontcheva AT, Sidlofsky S, Hanna WM, Qizilbash AH, Tweeddale ME, Fine S et al (2004) The combination of p53 mutation and neu\/erbB-2 amplification is associated with poor survival in node-negative breast cancer. J Clin Oncol 22:86\u201396","journal-title":"J Clin Oncol"},{"key":"2392_CR2","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1172\/JCI112694","volume":"78","author":"D Kerjaschki","year":"1986","unstructured":"Kerjaschki D, Poczewski H, Dekan G, Horvat R, Balzar E, Kraft N, Atkins RC (1986) Identification of a major sialoprotein in the glycocalyx of human visceral glomerular epithelial cells. J Clin Invest 78:1142\u20131149","journal-title":"J Clin Invest"},{"key":"2392_CR3","doi-asserted-by":"crossref","first-page":"15708","DOI":"10.1074\/jbc.272.25.15708","volume":"272","author":"DB Kershaw","year":"1997","unstructured":"Kershaw DB, Beck SG, Wharram BL, Wiggins JE, Goyal M, Thomas PE, Wiggins RC (1997) Molecular cloning and characterization of human podocalyxin-like protein. J Biol Chem 272:15708\u201315714","journal-title":"J Biol Chem"},{"key":"2392_CR4","doi-asserted-by":"crossref","first-page":"9001","DOI":"10.1074\/jbc.275.12.9001","volume":"275","author":"C Sassetti","year":"2000","unstructured":"Sassetti C, Van Zante A, Rosen SD (2000) Identification of endoglycan, a member of the CD34\/podocalyxin family of sialomucins. J Biol Chem 275:9001\u20139010","journal-title":"J Biol Chem"},{"key":"2392_CR5","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1083\/jcb.138.6.1395","volume":"138","author":"KM McNagny","year":"1997","unstructured":"McNagny KM, Pettersson I, Rossi F, Flamme I, Shevchenko A, Mann M, Graf T (1997) Thrombomucin, a novel cell surface protein that defines thrombocytes and multipotent hematopoietic progenitors. J Cell Biol 138:1395\u20131407","journal-title":"J Cell Biol"},{"key":"2392_CR6","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1365-2141.2004.04840.x","volume":"124","author":"L Kerosuo","year":"2004","unstructured":"Kerosuo L, Juvonen E, Alitalo R, Gylling M, Kerjaschki D, Miettinen A (2004) Podocalyxin in human haematopoietic cells. Br J Haematol 124:809\u2013818","journal-title":"Br J Haematol"},{"key":"2392_CR7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1084\/jem.194.1.13","volume":"194","author":"R Doyonnas","year":"2001","unstructured":"Doyonnas R, Kershaw DB, Duhme C, Merkens H, Chelliah S, Graf T, McNagny KM (2001) Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. J Exp Med 194:13\u201327","journal-title":"J Exp Med"},{"key":"2392_CR8","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1091\/mbc.11.9.3219","volume":"11","author":"T Takeda","year":"2000","unstructured":"Takeda T, Go WY, Orlando RA, Farquhar MG (2000) Expression of podocalyxin inhibits cell\u2013cell adhesion and modifies junctional properties in Madin-Darby canine kidney cells. Mol Biol Cell 11:3219\u20133232","journal-title":"Mol Biol Cell"},{"key":"2392_CR9","first-page":"343","volume":"118","author":"D Kerjaschki","year":"1985","unstructured":"Kerjaschki D, Vernillo AT, Farquhar MG (1985) Reduced sialyation of podocalyxin\u2013the major sialoprotein of the rat kidney glomerulus\u2013in aminonucleoside nephrosis. Am J Path 118:343\u2013349","journal-title":"Am J Path"},{"key":"2392_CR10","doi-asserted-by":"crossref","first-page":"e26025","DOI":"10.1371\/journal.pone.0026025","volume":"6","author":"M Pericacho","year":"2011","unstructured":"Pericacho M, Alonso-Martin S, Larrucea S, Gonz\u00e1lez-Manch\u00f3n C, Fern\u00e1ndez D, Sanchez I, Ayuso MS, Parrilla R (2011) Diminished thrombogenic responses by deletion of the podocalyxin gene in mouse megakaryocytes. PLoS One 6:e26025","journal-title":"PLoS One"},{"key":"2392_CR11","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1016\/j.thromres.2010.02.008","volume":"125","author":"S Alonso-Martin","year":"2010","unstructured":"Alonso-Martin S, Nowakowski A, Larrucea S, Fern\u00e1ndez D, Vilar-Egla M, Ayuso MS, Parrilla R (2010) Overexpression of podocalyxin in megakaryocytes and platelets decreases the bleeding time and enhances the agonist-induced aggregation of platelets. Thromb Res 125:e300\u2013e305","journal-title":"Thromb Res"},{"key":"2392_CR12","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/bjc.2011.295","volume":"105","author":"A Larsson","year":"2011","unstructured":"Larsson A, Johansson ME, Wangefjord S, Gaber A, Nodin B, Kucharzewska P, Welinder C, Belting M, Eberhard J, Johnsson A, Uhl\u00e9n M, Jirstr\u00f6m K (2011) Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer. Br J Cancer 105:666\u2013672","journal-title":"Br J Cancer"},{"key":"2392_CR13","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1158\/0008-5472.CAN-04-0240","volume":"64","author":"A Somasiri","year":"2004","unstructured":"Somasiri A, Nielsen JS, Makretsov N, McCoy ML, Prentice L, Gilks CB, Chia SK, Gelmon KA, Kershaw DB, Huntsman DG, McNagny KM, Roskelley CD (2004) Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression. Cancer Res 64:5068\u20135073","journal-title":"Cancer Res"},{"key":"2392_CR14","doi-asserted-by":"crossref","first-page":"C616","DOI":"10.1152\/ajpcell.00149.2012","volume":"303","author":"MR Dallas","year":"2012","unstructured":"Dallas MR, Chen SH, Streppel MM, Sharma S, Miatra A, Konstantopoulos K (2012) Sialofucosylated podocalyxin is a functional E- and L-selectin ligand expressed by metastatic pancreatic cancer cells. Am J Physiol 303:C616\u2013C624","journal-title":"Am J Physiol"},{"key":"2392_CR15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/jclinpath-2011-200359","volume":"65","author":"H Yasuoka","year":"2012","unstructured":"Yasuoka H, Tsujimoto M, Inagaki M, Kodama R, Tsuji H, Iwahashi Y, Mabuchi Y, Ino K, Sanke T, Nakamura Y (2012) Clinicopathological significance of podocalyxin and phosphorylated ezrin in uterine endometroid adenocarcinoma. J Clin Pathol 65:399\u2013402","journal-title":"J Clin Pathol"},{"key":"2392_CR16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1309\/7BHLAHHU0N4MHT7Q","volume":"124","author":"TW Kelley","year":"2005","unstructured":"Kelley TW, Huntsman D, McNagny KM, Roskelley CD, Hsi ED (2005) Podocalyxin: a marker of blasts in acute leukemia. Am J Clin Pathol 124:134\u2013142","journal-title":"Am J Clin Pathol"},{"key":"2392_CR17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1365-2559.2006.02489.x","volume":"49","author":"LC Heukamp","year":"2006","unstructured":"Heukamp LC, Fischer HP, Schirmacher P, Chen X, Breuhahn K, Nicolay C, Buttner R, Gutgemann I (2006) Podocalyxin-like protein 1 expression in primary hepatic tumours and tumour-like lesions. Histopathology 49:242\u2013247","journal-title":"Histopathology"},{"key":"2392_CR18","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1038\/sj.onc.1208517","volume":"24","author":"Y Naishiro","year":"2005","unstructured":"Naishiro Y, Yamada T, Idogawa M, Honda K, Takada M, Kondo T, Imai K, Hirohashi S (2005) Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein. Oncogene 24:3141\u20133153","journal-title":"Oncogene"},{"key":"2392_CR19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/IR:34:1:13","volume":"34","author":"SG Barton Furness","year":"2006","unstructured":"Barton Furness SG, McNagny K (2006) Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis. Immunol Res 34:13\u201332","journal-title":"Immunol Res"},{"key":"2392_CR20","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.yexcr.2008.03.009","volume":"314","author":"S Larrucea","year":"2008","unstructured":"Larrucea S, Butta N, Arias-Salgado EG, Alonso-Martin S, Ayuso MS, Parrilla R (2008) Expression of podocalyxin enhances the adherence, migration, and intercellular communication of cells. Exp Cell Res 314:2004\u20132015","journal-title":"Exp Cell Res"},{"key":"2392_CR21","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1158\/0008-5472.CAN-06-3575","volume":"67","author":"S Sizemore","year":"2007","unstructured":"Sizemore S, Cicek M, Sizemore N, Ng KP, Casey G (2007) Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin. Cancer Res 67:6183\u20136191","journal-title":"Cancer Res"},{"key":"2392_CR22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.0006-341X.2000.00227.x","volume":"56","author":"JP Sy","year":"2000","unstructured":"Sy JP, Taylor JM (2000) Estimation in a Cox proportional hazards cure model. Biometrics 56:227\u2013236","journal-title":"Biometrics"},{"key":"2392_CR23","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1200\/JCO.1998.16.4.1340","volume":"16","author":"IL Andrulis","year":"1998","unstructured":"Andrulis IL, Bull SB, Blackstein ME, Sutherland D, Mak C, Sidlofsky S, Pritzker KP, Hartwick RW, Hanna W, Lickley L, Wilkinson R, Qizilbash A et al (1998) neu\/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. J Clin Oncol 16:1340\u20131349","journal-title":"J Clin Oncol"},{"key":"2392_CR24","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1158\/1078-0432.CCR-07-4543","volume":"14","author":"AM Mulligan","year":"2008","unstructured":"Mulligan AM, Pinnaduwage D, Bull SB, O\u2019Malley FP, Andrulis IL (2008) Prognostic effect of basal-like breast cancers is time dependent: evidence from tissue microarray studies on a lymph node-negative cohort. Clin Cancer Res 14:4168\u20134174","journal-title":"Clin Cancer Res"},{"key":"2392_CR25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjc.6602678","volume":"93","author":"LM McShane","year":"2005","unstructured":"McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer 93:387\u2013391","journal-title":"Br J Cancer"},{"key":"2392_CR26","first-page":"155","volume":"11","author":"DC Allred","year":"1998","unstructured":"Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11:155\u2013168","journal-title":"Mod Pathol"},{"key":"2392_CR27","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/S0002-9440(10)64434-3","volume":"161","author":"CL Liu","year":"2002","unstructured":"Liu CL, Prapong W, Natkunam Y, Alizadeh A, Montgomery K, Gilks CB, van de Rijn M (2002) Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am J Pathol 161:1557\u20131565","journal-title":"Am J Pathol"},{"key":"2392_CR28","volume-title":"Analysis of survival data","author":"DR Cox","year":"1984","unstructured":"Cox DR, Oakes D (1984) Analysis of survival data. Chapman and Hall, London"},{"key":"2392_CR29","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2307\/2529885","volume":"38","author":"VT Farewell","year":"1982","unstructured":"Farewell VT (1982) The use of mixture models for the analysis of survival data with long-term survivors. Biometrics 38:1041\u20131046","journal-title":"Biometrics"},{"key":"2392_CR30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0169-2607(01)00149-3","volume":"67","author":"G Heinze","year":"2002","unstructured":"Heinze G, Ploner M (2002) SAS and SPLUS programs to perform Cox regression without convergence problems. Comput Methods Programs Biomed 67:217\u2013223","journal-title":"Comput Methods Programs Biomed"},{"key":"2392_CR31","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1681\/ASN.2008070782","volume":"20","author":"JS Nielsen","year":"2009","unstructured":"Nielsen JS, McNagny KM (2009) The role of podocalyxin in health and disease. J Am Soc Nephrol 20:1669\u20131676","journal-title":"J Am Soc Nephrol"},{"key":"2392_CR32","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","volume":"17","author":"JM Harvey","year":"1999","unstructured":"Harvey JM, Clark GM, Osborne CK, Allred DC (1999) Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17:1474\u20131481","journal-title":"J Clin Oncol"},{"key":"2392_CR33","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/modpathol.3800229","volume":"17","author":"SK Mohsin","year":"2004","unstructured":"Mohsin SK, Weiss H, Havighurst T, Clark GM, Berardo M, Roanh LD, To TV, Zho Q, Love RR, Allred DC (2004) Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study. Mod Pathol 17:1545\u20131554","journal-title":"Mod Pathol"},{"key":"2392_CR34","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1309\/VP4W-5C55-7M09-6TX3","volume":"115","author":"FP O\u2019 Malley","year":"2001","unstructured":"O\u2019 Malley FP, Parkes R, Latta E, Tjan S, Zadro T, Mueller R, Arneson N, Blackstein M, Andrulis I (2001) Comparison of HER2\/neu status assessed by quantitative polymerase chain reaction and immunohistochemistry. Am J Clin Pathol 115:504\u2013511","journal-title":"Am J Clin Pathol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-2392-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-012-2392-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-2392-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:47:11Z","timestamp":1559234831000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-012-2392-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,4]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["2392"],"URL":"https:\/\/doi.org\/10.1007\/s10549-012-2392-y","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,4]]}}}